Cardiovascular risk reduction in obesity: Difference between revisions
| [unchecked revision] | [unchecked revision] |
MDElliottMD (talk | contribs) Auto-create stub from pcp_problem migration |
MDElliottMD (talk | contribs) Launch A7: honest early-note placeholder (mark-tapped) |
||
| Line 1: | Line 1: | ||
<span class="pcp-early-note">This page is early; a full clinical description is coming. The cross-linked medicines below are live.</span> | |||
Reduction of MACE in adults with obesity but without type 2 diabetes (SELECT trial indication). | Reduction of MACE in adults with obesity but without type 2 diabetes (SELECT trial indication). | ||
Latest revision as of 06:01, 13 June 2026
This page is early; a full clinical description is coming. The cross-linked medicines below are live.
Reduction of MACE in adults with obesity but without type 2 diabetes (SELECT trial indication).